Semaglutide
GLP-1 receptor agonist for metabolic pathway research.
Research chemical · Not for human use
$79.99
Download sample COAResearch description
Semaglutide is a GLP-1 receptor agonist peptide analog used in laboratory research examining glucose metabolism, insulin secretion pathways, and GLP-1 receptor binding in preclinical models.
Intended solely as a laboratory reference material. No claims are made regarding safety, efficacy, or suitability for any clinical, therapeutic, or personal use.
Research Applications
- GLP-1 receptor binding assays
- Glucose metabolism and insulin secretion studies
- Appetite-regulation pathway research (in vitro)
- Cardiovascular risk factor models
Reviews
Batch COA matched HPLC results
Ran our own HPLC — purity within 0.1% of HelixHouse's COA. Impressive consistency.
Lab Director, Northeast
Storage
- Lyophilized
- -20°C, light-protected
- Reconstituted
- 2–8°C, 28 days
Laboratory reconstitution
- Recommended diluent
- Bacteriostatic water
- Concentration
- 1–2 mg/mL
Guidance for in vitro laboratory preparation only — not dosing or administration instructions.
Related research materials
Tirzepatide
RUO · Lab research only
Dual GIP/GLP-1 agonist for advanced metabolic research.
Retatrutide
RUO · Lab research only
Triple agonist (GIP/GLP-1/Glucagon) reference material for metabolic pathway research.
Metabolic Pathway Bundle
RUO · Lab research only
Semaglutide + Tirzepatide laboratory research bundle.